EBITDA CAGR uses clean operating EBITDA derived from reported operating income plus depreciation and amortization.
Over the past 12 months, EBITDA CAGR is -26.96%. EBITDA CAGR shows how the company's operating profitability has grown before depreciation and amortization. This reflects the growth of the core business's cash-operating earnings power, independent of capital-intensity and accounting depreciation choices.
Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
Reported quarterly EBITDA; no daily interpolation. Q2 FY2026 (2026-06-30): $19.08M.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A Quote observation: 2026-10-06T19:52:54.305Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Year | Start EBITDA | End EBITDA | Change | % Change |
|---|---|---|---|---|
| 2025 | $112.40M | $82.12M | −$30.28M | -26.94% |
| 2024 | $94.58M | $112.40M | +$17.82M | +18.84% |
| Period | Period End | Value | QoQ Growth | YoY Growth |
|---|---|---|---|---|
| Q2 FY2026 | 2026-06-30 | $19.08M | +2.8% | N/A |
| Q1 FY2026 | 2026-03-31 | $18.57M | +277.0% | N/A |
| Q4 FY2025 | 2025-12-31 | $4.92M | -81.3% | N/A |
| Q3 FY2025 | 2025-09-30 | $26.36M | N/A | N/A |
| Q1 FY2025 | 2025-03-31 | $22.85M | -20.7% | N/A |
| Q4 FY2024 | 2024-12-31 | $28.83M | N/A |
| N/A |
QoQ Growth compares the previous fiscal quarter; YoY Growth compares the same fiscal quarter in the prior fiscal year. Missing or ambiguous fiscal periods render N/A.
